ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
KemPharm Receives of Two Additional U.S. Patents americanpharmaceuticalreview
August 04, 2020KemPharm announced the United States Patent and Trademark Office (USPTO) has recently issued two new patents to KemPharm governing methods of use and composition of matter for methylphenidate-based prodrugs. -
KemPharm Submits KP415 NDA to FDA for ADHD americanpharmaceuticalreview
March 04, 2020KemPharm has submitted a New Drug Application (NDA) under Section 505(b)(2) of the Federal Food, Drug and Cosmetic Act for its investigational product candidate, KP415, to the U.S. Food and Drug Administration (FDA).
Pharma Sources Insight January 2025
